Opus Capital Group, LLC
- SEC CIK
- 0001330325
- Latest filing
- Jul 31, 2026
SLS holding history
SELLAS Life Sciences Group, Inc. in every 13F filed by Opus Capital Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SLS overviewAll 13F holders of SLSFull Q2 2026 holdings
- Shares (Q2 2026)
- 385,604
- Value
- $5.69M
- % of portfolio
- 0.6%
- Quarters held
- 15
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 385,604 | $5.69M | 0.6% | +39,152+11.3% | Added | Holders |
| Q1 2026 | 346,452 | $1.47M | 0.2% | +29,352+9.3% | Added | Holders |
| Q4 2025 | 317,100 | $1.20M | 0.1% | +67,100+26.8% | Added | Holders |
| Q3 2025 | 250,000 | $403.0K | <0.1% | +10,000+4.2% | Added | Holders |
| Q2 2025 | 240,000 | $526.0K | 0.1% | +500+0.2% | Added | Holders |
| Q1 2025 | 239,500 | $259.0K | <0.1% | +1,000+0.4% | Added | Holders |
| Q4 2024 | 238,500 | $248.0K | <0.1% | +12,400+5.5% | Added | Holders |
| Q3 2024 | 226,100 | $283.0K | <0.1% | +5,100+2.3% | Added | Holders |
| Q2 2024 | 221,000 | $263.0K | <0.1% | +20,400+10.2% | Added | Holders |
| Q1 2024 | 200,600 | $203.0K | <0.1% | +65,600+48.6% | Added | Holders |
| Q4 2023 | 135,000 | $143.0K | <0.1% | +100,500+291.3% | Added | Holders |
| Q3 2023 | 34,500 | $57.0K | <0.1% | +3,500+11.3% | Added | Holders |
| Q2 2023 | 31,000 | $49.0K | <0.1% | +6,000+24.0% | Added | Holders |
| Q1 2023 | 25,000 | $36.0K | <0.1% | +5,328+27.1% | Added | Holders |
| Q4 2022 | 19,672 | $46.0K | <0.1% | +19,672 | New | Holders |